Research
Study of Maternal and Fetal Outcome in Covid 19 Pregnancy
Background: Coronavirus has created a pandemic and extraordinary global Health crisis. Coronavirus disease 2019 (COVID-19) is an illness caused by a novel coronavirus now called Severe acute respiratory syndrome coronavirus 2(SARS – COV-2). The virus can cause mild to severe respiratory diseases. The objective of this study is to summarize the Maternal and Fetal outcome in COVID-19 Pregnancies. Materials and Methods: We conducted an observational study over two months in the Department of Obstetrics, and Gynaecology, at a COVID care Centre, Cama and Albless Hospital, Mumbai. The study enrolled a total of 192 COVID positive pregnant women with inclusion and exclusion criteria. We noted, Antepartum, Intrapartum and Neonatal parameters using preformed proforma. Results: In our study, we observed that most COVID positive pregnant women belonged to the age group of 25-29years.COVID-19 is more prevalent among primigravida (35%). Preeclampsia (37%) is more commonly associated with COVID patients. The Majority of pregnancies (74%) extended till Term. Vaginal Delivery (60%) was the most common mode of Delivery. 10% COVID positive pregnant women admitted to the Intensive Care Unit. Maternal Mortality was 4% among COVID positive pregnancies. 13% of the babies tested COVID positive born to COVID positive mothers. NICU admission was required for 38% of the positive babies. Only one neonatal death occurred among COVID positive babies.
